Treatment (n,%)
| Steroid/pulse treatment | 149 (99.3%)/38 (25.3%) |
|---|---|
| Hydroxycholoroquine | 150 (100%) |
| Azathioprine | 107 (71.3%) |
| Mycophenolate mofetil | 55 (36.7%) |
| Cyclophosphamide (iv) | 45 (30%); 10±4.5 cycles |
| Rituximab | 15 (10%) |
| Warfarin | 31 (20.7%) |
| Intravenous immunglobulin (IVIG) | 3 (2%) |
| Plasmapheresis | 2 (1.3%) |